Evidence map›Paper›PMID 34805742›Full record

SynthesisJNCI cancer spectrum2021

Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.

Nagisa Mori, Pekka Keski-Rahkonen, Audrey Gicquiau, Sabina Rinaldi, Niki Dimou, Sophia Harlid, Justin Harbs, Bethany Van Guelpen, Dagfinn Aune, Amanda J Cross and 23 more

Open access · goldAbstract readMeta-AnalysisMulticenter Study
In one paragraph

Synthesis in JNCI cancer spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. 17β-estradiol in colorectal cancer: friend or foe?Cell communication and signaling : CCS · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 18 institutions in 10 countries.

Nagisa MoriNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-1721-4083
Pekka Keski-RahkonenNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0001-9437-3040
Audrey GicquiauNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Sabina RinaldiNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-6846-1204
Niki DimouNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Sophia HarlidDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.ORCID 0000-0001-8540-6891
Justin HarbsDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.ORCID 0000-0002-4759-2643
Bethany Van GuelpenDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Dagfinn AuneDepartment of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, London, UK.ORCID 0000-0002-4533-1722
Amanda J CrossDepartment of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, London, UK.ORCID 0000-0002-0893-2377
Konstantinos K TsilidisDepartment of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, London, UK.ORCID 0000-0002-8452-8472
Gianluca SeveriParis-Saclay University, UVSQ, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP, Villejuif, France.ORCID 0000-0001-7157-419X
Marina KvaskoffParis-Saclay University, UVSQ, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP, Villejuif, France.ORCID 0000-0002-4557-3772
Agnès FournierParis-Saclay University, UVSQ, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP, Villejuif, France.ORCID 0000-0001-8380-3439
Rudolf KaaksDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Renée Turzanski FortnerDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-1426-8505
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition, Potsdam, Germany.ORCID 0000-0002-0830-5277
Paula JakszynUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
Maria-Jose SánchezEscuela Andaluza de Salud Pública (EASP), Granada, Spain.
Sandra M Colorado-YoharDepartment of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Eva ArdanazCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.ORCID 0000-0001-8434-2013
Ruth TravisCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Eleanor L WattsCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0001-9229-2589
Giovanna MasalaInstitute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.ORCID 0000-0002-5758-9069
Vittorio KroghEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0003-0122-8624
Rosario TuminoCancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), Ragusa, Italy.ORCID 0000-0003-2666-414X
Carlotta SacerdoteUnit of Cancer Epidemiology, Piedmont Children Cancer Registry, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.ORCID 0000-0002-8008-5096
Salvatore PanicoDipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Bas Bueno-de-MesquitaCentre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Inger Torhild GramFaculty of Health Sciences, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-0031-4152
Marit WaasethDepartment of Pharmacy, The Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Marc J GunterNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Neil MurphyNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Centre international de recherche sur le cancer · FRInserm · FRUmeå University · SEGerman Cancer Research Center · DEUiT The Arctic University of Norway · NOUniversity of Oxford · GBFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEImperial College London · GBInstitut Català d'Oncologia · ESInstituto de Salud Pública de Navarra · ESNational Institute for Public Health and the Environment · NLOslo University Hospital · NOPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversidad de Antioquia · COUniversidad de Granada · ESUniversity of Ioannina · GR

Funding

Cancer Research UK 25004Cancer Research UK 29017Cancer Research UK C8221/A29017Medical Research Council MR/M012190/1World Health Organization 001
6 · The paper itself

Abstract

Background: Observational studies have consistently reported that postmenopausal hormone therapy use is associated with lower colon cancer risk, but epidemiologic studies examining the associations between circulating concentrations of endogenous estrogens and colorectal cancer have reported inconsistent results. Methods: We investigated the associations between circulating concentrations of estrone, estradiol, free estradiol, testosterone, free testosterone, androstenedione, dehydroepiandrosterone (DHEA), progesterone, and sex hormone-binding globulin (SHBG) with colon cancer risk in a nested case-control study of 1028 postmenopausal European women (512 colon cancer cases, 516 matched controls) who were noncurrent users of exogenous hormones at blood collection. Multivariable conditional logistic regression models were used to compute odds ratios and 95% confidence intervals to evaluate the association between circulating sex hormones and colon cancer risk. We also conducted a dose-response meta-analysis of prospective studies of circulating estrone and estradiol with colorectal, colon, and rectal cancer risk in postmenopausal women. All statistical tests were 2-sided. Results: In the multivariable model, a nonstatistically significantly positive relationship was found between circulating estrone and colon cancer risk (odds ratio per log Conclusion: Our observational and meta-analysis results do not support an association between circulating concentrations of endogenous sex hormones and colon or rectal cancer in postmenopausal women.

Indexed as

AndrostenedioneCase-Control StudiesColonic NeoplasmsConfidence IntervalsDehydroepiandrosterone SulfateEstradiolEstrogensEstroneEuropeFemaleGonadal Steroid HormonesHumansLogistic ModelsMiddle AgedOdds RatioPostmenopauseAndrostenedioneDehydroepiandrosterone SulfateEstradiolEstrogensEstroneGonadal Steroid HormonesProgesteroneSex Hormone-Binding GlobulinSHBG protein, humanTestosterone

Identifiers

PMID34805742
PMCPMC8598284
OpenAlexW3202793332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.